Health news roundup: Developing countries should reap benefits of new monkeypox research, experts urge; France says number of confirmed monkeypox cases has risen to 33 and more

Here is a summary of health news briefs.

Developing world should reap benefits of new monkeypox research, experts urge

As cases of monkeypox in wealthier Western countries spark a wave of scientific research to tackle the epidemic, scientists are urging the world to ensure that low-income countries also benefit from the fruits of this labor. According to the World Health Organization (WHO), more than 550 confirmed cases of monkeypox have been reported from at least 30 countries outside of Africa, where the virus is commonly present.

France says number of confirmed monkeypox cases has risen to 33

The number of confirmed cases of monkeypox in France has risen to 33 from 17 earlier this week, health authorities announced on Thursday. Health body Santé Publique France (SPF) said there were 33 cases as of June 1, including 24 in the Paris/Ile-de-France region. This compared to 17 confirmed cases as of May 30.

Pfizer’s Paxlovid reduces risk of COVID in older adults, regardless of vaccination status – study

Pfizer Inc’s antiviral treatment Paxlovid reduces COVID-19-related hospitalization and death rates in vaccinated and unvaccinated patients 65 years and older, according to a new study in Israel conducted during the rise of the Omicron variant of the coronavirus. However, the treatment failed to prevent serious illness in young adults, according to a study by Clalit Health Services, Israel’s largest healthcare provider.

Vaccination during pregnancy reduces childhood infections; vaccines only modestly reduce long-term COVID risk

Here is a summary of some recent studies on COVID-19. They include research that deserves further study to corroborate the findings and that has not yet been certified by peer review. Vaccines in pregnancy reduce infants’ risk of COVID-19

Immunizations for young children could start ‘in earnest’ by June 21 – White House

The White House expects vaccinations for young children to begin in earnest as soon as June 21, if federal authorities approve their use in the coming weeks, White House COVID Response Coordinator Ashish Jha said Thursday. . Jha told reporters that the US government has enough COVID-19 vaccines from Pfizer Inc and Moderna Inc to begin the program for young children if and when the vaccines are approved.

Bristol Myers and J&J drugs reduce COVID death rates in NIH study

A late-stage study of two rheumatoid arthritis drugs from Bristol Myers Squibb and Johnson & Johnson has shown a significant drop in deaths among hospitalized COVID patients, a US health agency said Thursday. However, the two drugs failed to achieve the primary goal of speeding up recovery compared to a placebo, the National Institutes of Health (NIH) study of nearly 2,000 patients showed.

South Korea to lift quarantine requirement for unvaccinated foreign arrivals

South Korea’s prime minister said on Friday the country will lift its quarantine requirement for foreign arrivals without vaccinations from June 8 and will also start lifting aviation regulations imposed on international flights. However, the government will maintain the requirement for a negative polymerase chain reaction (PCR) test result before entry and a PCR test within 72 hours of arrival.

North Korea reports 82,160 more people with fever symptoms amid COVID outbreak – KCNA

North Korea has reported 82,160 more people with symptoms of fever as part of its nationwide lockdown to stop the first confirmed outbreak of COVID-19 in the impoverished economy, the news outlet said on Friday. KCNA State. The media did not mention if there had been any new deaths.

Federal investigators to review FDA response to infant formula recall

Federal investigators have launched a review to determine whether the U.S. Food and Drug Administration properly inspected Abbott Laboratories’ Michigan plant and how the agency oversaw the infant formula recall that led to severe shortages in the USA. The review, which is expected to be completed in 2023, will be conducted by the Office of Inspector General (OIG) of the U.S. Department of Health and Human Services, according to a notice posted Thursday on its website.

Factbox-Global infant formula makers are sending products to restock US shelves

Global companies that make infant formula are bringing products to the United States after the country’s health regulator eased its import policy to deal with a nationwide shortage partly triggered by the recall of some products by the US. Abbott Laboratories manufacturing plant in Michigan in February. Importers include Neocate maker Danone SA, while New Zealand dairy giants Fonterra and a2 Milk have filed applications with the US Food and Drug Administration (FDA) to supply infant formula in the United States.

(With agency contributions.)